PTC Therapeutics

Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

Date Title and Summary View
Oct 27, 2014
Data Supports Benefit in Nonsense Mutation Duchenne Muscular Dystrophy Patients
Additional Formats
Oct 23, 2014
SOUTH PLAINFIELD, N.J. , Oct. 23, 2014 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2014 financial results and provide an update on the company's business and outlook on Thursday, November 6,
Additional Formats
Oct 09, 2014
SOUTH PLAINFIELD, N.J. , Oct. 9, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the pricing of an underwritten public offering of 3,000,000 shares of its common stock pursuant to an automatically effective shelf registration statement that was previously filed with the
Additional Formats
Oct 08, 2014
SOUTH PLAINFIELD, N.J. , Oct. 8, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it is commencing an underwritten public offering of 3,000,000 shares of its common stock pursuant to an automatically effective shelf registration statement that was previously filed
Additional Formats
Sep 24, 2014
SOUTH PLAINFIELD, N.J. , Sept. 24, 2014 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the Leerink Partners Rare Disease Roundtable on Wednesday, October 1st at 8:25 am ET at Le Parker Meridien in New York City .
Additional Formats
Sep 24, 2014
SOUTH PLAINFIELD, N.J. , Sept. 24, 2014 /PRNewswire/ --   PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 23, 2014 it approved non-statutory stock options to purchase an aggregate of 208,300 shares of its common stock to eighteen new employees.
Additional Formats
Sep 17, 2014
SOUTH PLAINFIELD, N.J. , Sept. 17, 2014 /PRNewswire/ --  PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the expansion of its global presence with the addition of key executives to leadership positions in PTC's global commercial team and the establishment of its international headquarters
Additional Formats
Sep 09, 2014
- Top-line data expected H2 2015- -Data intended to support applications for additional approvals globally–
Additional Formats
Aug 20, 2014
PTC THERAPEUTICS TO PARTICIPATE AT UPCOMING INVESTOR CONFERENCES SOUTH PLAINFIELD, NJ – August 20, 2014 –PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that it will participate at two upcoming investor conferences:  FBR 1st Annual Healthcare Conference at the Four Seasons Hotel in Boston on
Additional Formats
Aug 07, 2014
-Conference Call Today at 8:30 am ET-
Additional Formats